Recent BioUtah News & Events

Myriad to establish new Walter Gilbert Research and Innovation Center Company also cited among 2022 Top Workplaces USA National List by Energage

BRACAnalysis CDx is now the only germline test approved by FDA as a companion diagnostic for treatment of HER2 negative high-risk early-stage breast cancer

Company launches Precise™ Tumor test, part of a comprehensive suite combining germline, tumor and companion diagnostics in one easy-to-access solution

Acquisition offers new, differentiated, and potentially best-in-class approach to address needs of a broader number of patients with immuno-inflammatory diseases

PolarityTE Announces $5.0 Million Registered Direct Offering

The Senate HELP Committee on Tuesday voted 20-2 to advance legislation, the PREVENTS Pandemic Act.

Co-Diagnostics announced that its Board of Directors has authorized a share repurchase program that would allow the Company to repurchase up to $30 million of CODX common stock.

Legislation would combat corrupt Chinese Courts from issuing “anti-suit injunctions” that prevent companies from challenging patent infringement from Chinese companies in American courts.

The 2022 Wilson Sonsini Entrepreneur and Investor Life Sciences Summit presented by BioUtah, BioHive and the PIVOT Center attracted a record setting 300+ registrants along with an impressive line-up of distinguished speakers, national and local investors and numerous Utah life sciences startups. Now in its 7th year, the Summit (our first in person since COVID-19) […]

Xenter has leased 30,000 square feet to accommodate explosive growth in the new Irvine Office Park in Draper, Utah.

myIntelX will be launching in conjunction with KidneyIntelX going live at Atrium Health, and will expand testing services across all Renalytix healthcare provider partners

IONIQ Sciences announced that it has acquired from OT Acceptance, LLC certain intellectual property formerly licensed to the Company by OT Acceptance.

Innovative Embolic Device by Fluidx Medical Used Successfully in a Variety of Complex Cancer Cases

Collaboration aims to capture patient-to-patient variability to determine the best treatment for every cancer

Halia Therapeutics New Leadership Team

BD Names William ‘Bill’ Brown to Board of Directors

Allogeneic discogenic cell therapy was well tolerated and produced clinically meaningful, statistically significant improvements in low back pain, function, and quality of life by 12 weeks following intradiscal injection; improvements were sustained at the one-year interim readout with additional data to follow at 18 and 24 months.

Merit Medical shares were up today on fourth-quarter results that topped the consensus forecast.

Americans with diabetes will have access to more affordable insulins through a transparent, cost-plus model

BioUtah Legislative Update

MDMA Urgent Request: Medical Supplies for Ukraine Needed

ARUP Laboratories has renamed its expert team of healthcare consultants as ARUP Healthcare Advisory Services.

Foldax announced the presentation of results from the first animal study of its transcatheter valve from the TRIA™ biopolymer heart valve portfolio

Over the last couple of weeks, health legislative staff for Utah Reps. Chris Stewart (R-UT) and John Curtis (R-UT) have been touring a number of the state’s life sciences companies to learn more about their innovative work and our growing BioHive.  Colleen Malloy White, on behalf of Curtis, visited IONIQ Sciences, ARUP Laboratories and ATL […]